Glenmark Life Sciences Limited (GLS.NS)
INR 1086.0
(0.15%)
INR 1086.0
(0.15%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 11.64 Billion INR | 20.75% |
| 2022 | 5.46 Billion INR | 9.08% |
| 2021 | 5.01 Billion INR | 19.97% |
| 2020 | 4.17 Billion INR | 3.7% |
| 2019 | 4.03 Billion INR | 9.13% |
| 2018 | 3.69 Billion INR | 1538683.33% |
| 2017 | 240 Thousand INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.62 Billion INR | 0.46% |
| 2024 Q1 | 844.98 Million INR | -50.58% |
| 2023 Q4 | 1.7 Billion INR | -0.14% |
| 2023 FY | 6.6 Billion INR | 20.75% |
| 2023 Q3 | 1.71 Billion INR | 1.73% |
| 2023 Q2 | 1.68 Billion INR | 12.32% |
| 2023 Q1 | 1.49 Billion INR | 2.62% |
| 2022 Q3 | 1.41 Billion INR | 4.12% |
| 2022 Q2 | 1.35 Billion INR | 9.3% |
| 2022 Q1 | 1.24 Billion INR | -1.16% |
| 2022 FY | 5.46 Billion INR | 9.08% |
| 2022 Q4 | 1.46 Billion INR | 3.42% |
| 2021 FY | 5.01 Billion INR | 19.97% |
| 2021 Q1 | 1.13 Billion INR | 4.4% |
| 2021 Q4 | 1.25 Billion INR | -2.69% |
| 2021 Q3 | 1.29 Billion INR | -2.91% |
| 2021 Q2 | 1.32 Billion INR | 16.56% |
| 2020 Q4 | 1.09 Billion INR | -0.87% |
| 2020 Q1 | 902.6 Million INR | 0.0% |
| 2020 Q3 | 1.1 Billion INR | 1.74% |
| 2020 Q2 | 1.08 Billion INR | 19.94% |
| 2020 FY | 4.17 Billion INR | 3.7% |
| 2019 FY | 4.03 Billion INR | 9.13% |
| 2018 FY | 3.69 Billion INR | 1538683.33% |
| 2017 FY | 240 Thousand INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 26.648% |
| Hester Biosciences Limited | 908.84 Million INR | -1180.829% |
| Aarti Drugs Limited | 1.16 Billion INR | -897.079% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -278.633% |
| Albert David Limited | 1.02 Billion INR | -1034.408% |
| Alembic Limited | 872.45 Million INR | -1234.241% |
| Alkem Laboratories Limited | 32.83 Billion INR | 64.548% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -2455.108% |
| Bajaj HealthCare Limited | 985.34 Million INR | -1081.382% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -170584.604% |
| Brooks Laboratories Limited | 51.18 Million INR | -22644.607% |
| Eris Lifesciences Limited | 4.94 Billion INR | -135.501% |
| FDC Limited | 3.49 Billion INR | -232.614% |
| Gufic Biosciences Limited | 1.18 Billion INR | -881.021% |
| Hikal Limited | 4.46 Billion INR | -160.78% |
| Ind-Swift Limited | 946.56 Million INR | -1129.78% |
| Innova Captab Limited | 931.03 Million INR | -1150.302% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -428.882% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -2554.359% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 19.464% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -983.675% |
| Lupin Limited | 125.09 Billion INR | 90.695% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -7075.512% |
| Medico Remedies Limited | 59.67 Million INR | -19406.812% |
| Morepen Laboratories Limited | 1.98 Billion INR | -485.71% |
| Nectar Lifesciences Limited | 932.7 Million INR | -1148.064% |
| Orchid Pharma Limited | 800.77 Million INR | -1353.685% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -288.619% |
| RPG Life Sciences Limited | 1.63 Billion INR | -611.751% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -2722.485% |
| Sigachi Industries Limited | 579.88 Million INR | -1907.407% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -355.765% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -729.825% |
| Themis Medicare Limited | 1.12 Billion INR | -933.995% |
| Unichem Laboratories Limited | 6.72 Billion INR | -73.073% |
| Vaishali Pharma Limited | 84.02 Million INR | -13753.182% |
| Wanbury Limited | 978.96 Million INR | -1089.08% |
| Windlas Biotech Limited | 1 Billion INR | -1056.54% |
| ZIM Laboratories Limited | 1.01 Billion INR | -1049.065% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -448.008% |
| Ipca Laboratories Limited | 18.98 Billion INR | 38.693% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 92.45% |
| Venus Remedies Limited | 1.91 Billion INR | -507.462% |
| Sakar Healthcare Limited | 204.07 Million INR | -5604.012% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 79.085% |
| Divi's Laboratories Limited | 14.17 Billion INR | 17.85% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -370.616% |
| Mankind Pharma Limited | 29.27 Billion INR | 60.234% |
| Sequent Scientific Limited | 2.9 Billion INR | -301.153% |
| Laurus Labs Limited | 11.9 Billion INR | 2.26% |
| Neuland Laboratories Limited | 2.92 Billion INR | -297.328% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 21.307% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 75.208% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 90.703% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -455.897% |
| Wockhardt Limited | 8.48 Billion INR | -37.272% |
| Bal Pharma Limited | 555.62 Million INR | -1995.059% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 87.859% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -720.216% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -19870.982% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -435.327% |
| Shilpa Medicare Limited | 3.33 Billion INR | -249.132% |
| Valiant Laboratories Limited | 138.02 Million INR | -8333.51% |
| Ajanta Pharma Limited | 30.46 Billion INR | 61.787% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -81801.71% |
| Granules India Limited | 10.31 Billion INR | -12.876% |
| Medicamen Biotech Limited | 335.16 Million INR | -3373.101% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -3267.934% |
| Piramal Enterprises Limited | 63.65 Billion INR | 81.712% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 45.66% |
| NATCO Pharma Limited | 10.05 Billion INR | -15.736% |
| Suven Life Sciences Limited | 109.75 Million INR | -10506.551% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -25120.318% |
| Strides Pharma Science Limited | 9.16 Billion INR | -27.05% |
| Indoco Remedies Limited | 12.06 Billion INR | 3.487% |
| Alpa Laboratories Limited | 127.38 Million INR | -9038.554% |
| Lasa Supergenerics Limited | 291.17 Million INR | -3897.847% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -278.338% |